DeCS Inglês+escopo

serw-MX [xml]

DeCS Categories

B01 Eukaryota .
B01.650 Plants .
B01.650.940 Viridiplantae .
B01.650.940.800 Streptophyta .
B01.650.940.800.575 Embryophyta .
B01.650.940.800.575.912 Tracheophyta .
B01.650.940.800.575.912.250 Magnoliopsida .
B01.650.940.800.575.912.250.075 Apiaceae .
B01.650.940.800.575.912.250.075.300 Ferula .
B01.650.940.800.575.912.250.096 Aristolochiaceae .
B01.650.940.800.575.912.250.096.233 Asarum .
C10 Nervous System Diseases .
C10.228 Central Nervous System Diseases .
C10.228.140 Brain Diseases .
C10.228.140.163 Brain Diseases, Metabolic .
C10.228.140.163.100 Brain Diseases, Metabolic, Inborn .
C10.228.140.163.100.937 Urea Cycle Disorders, Inborn .
C10.228.140.163.100.937.124 Argininosuccinic Aciduria .
C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities .
C16.320 Genetic Diseases, Inborn .
C16.320.565 Metabolism, Inborn Errors .
C16.320.565.100 Amino Acid Metabolism, Inborn Errors .
C16.320.565.100.940 Urea Cycle Disorders, Inborn .
C16.320.565.100.940.124 Argininosuccinic Aciduria .
C16.320.565.189 Brain Diseases, Metabolic, Inborn .
C16.320.565.189.937 Urea Cycle Disorders, Inborn .
C16.320.565.189.937.124 Argininosuccinic Aciduria .
C18 Nutritional and Metabolic Diseases .
C18.452 Metabolic Diseases .
C18.452.132 Brain Diseases, Metabolic .
C18.452.132.100 Brain Diseases, Metabolic, Inborn .
C18.452.132.100.937 Urea Cycle Disorders, Inborn .
C18.452.132.100.937.124 Argininosuccinic Aciduria .
C18.452.648 Metabolism, Inborn Errors .
C18.452.648.100 Amino Acid Metabolism, Inborn Errors .
C18.452.648.100.940 Urea Cycle Disorders, Inborn .
C18.452.648.100.940.124 Argininosuccinic Aciduria .
C18.452.648.189 Brain Diseases, Metabolic, Inborn .
C18.452.648.189.937 Urea Cycle Disorders, Inborn .
C18.452.648.189.937.124 Argininosuccinic Aciduria .
D02 Organic Chemicals .
D02.241 Carboxylic Acids .
D02.241.223 Acids, Carbocyclic .
D02.241.223.100 Benzoates .
D02.241.223.100.050 Aminobenzoates .
D02.241.223.100.050.300 meta-Aminobenzoates .
D02.241.223.100.050.300.500 Mesalamine .
D02.241.223.100.300 Hydroxybenzoates .
D02.241.223.100.300.595 Salicylates .
D02.241.223.100.300.595.100 Aminosalicylic Acids .
D02.241.223.100.300.595.100.540 Mesalamine .
D02.241.511 Hydroxy Acids .
D02.241.511.390 Hydroxybenzoates .
D02.241.511.390.595 Salicylates .
D02.241.511.390.595.100 Aminosalicylic Acids .
D02.241.511.390.595.100.540 Mesalamine .
D02.455 Hydrocarbons .
D02.455.426 Hydrocarbons, Cyclic .
D02.455.426.559 Hydrocarbons, Aromatic .
D02.455.426.559.389 Benzene Derivatives .
D02.455.426.559.389.127 Benzoates .
D02.455.426.559.389.127.020 Aminobenzoates .
D02.455.426.559.389.127.020.452 meta-Aminobenzoates .
D02.455.426.559.389.127.020.452.750 Mesalamine .
D02.455.426.559.389.127.281 Hydroxybenzoates .
D02.455.426.559.389.127.281.595 Salicylates .
D02.455.426.559.389.127.281.595.100 Aminosalicylic Acids .
D02.455.426.559.389.127.281.595.100.540 Mesalamine .
D02.455.426.559.389.657 Phenols .
D02.455.426.559.389.657.410 Hydroxybenzoates .
D02.455.426.559.389.657.410.595 Salicylates .
D02.455.426.559.389.657.410.595.100 Aminosalicylic Acids .
D02.455.426.559.389.657.410.595.100.540 Mesalamine .
D02.455.426.559.389.657.410.595.176 Aspirin .
D02.455.426.559.389.657.410.595.176.500 Aspirin, Dipyridamole Drug Combination .
D03 Heterocyclic Compounds .
D03.383 Heterocyclic Compounds, 1-Ring .
D03.383.742 Pyrimidines .
D03.383.742.175 Dipyridamole .
D03.383.742.175.500 Aspirin, Dipyridamole Drug Combination .
D26 Pharmaceutical Preparations .
D26.310 Drug Combinations .
D26.310.125 Aspirin, Dipyridamole Drug Combination .
HP4 Materia Medica .
HP4.018 Homeopathic Remedy .
HP4.018.127 Homeopathic Remedy A .
HP4.018.127.575 Asarum europaeum .

Terms
Synonyms & Historicals

Documents
LILACS e MDL

Mesalamine .
5-Aminosalicylic Acid .
Asacol .
Asacolon .
Ascolitin .
Canasa .
Claversal .
Fivasa .
Lixacol .
Mesalamine Hydrochloride .
Mesalamine Monosodium Salt .
Mesasal .
Novo-5 ASA .
Pentasa .
Rowasa .
Salofalk .
m-Aminosalicylic Acid .
meta-Aminosalicylic Acid .
5 Aminosalicylate .
5 Aminosalicylic Acid .
Hydrochloride, Mesalamine .
Monosodium Salt, Mesalamine .
Novo 5 ASA .
m Aminosalicylic Acid .
meta Aminosalicylic Acid .
Mesalazine .
5-Aminosalicylate .
An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed) .
1.00

Ferula .
Asa-foetida .
Asafetida .
Ferula foetida .
Ferula harmonis .
Ferula hermonis .
Zallouh .
Asa foetida .
Asa-foetidas .
Asafetidas .
Asafoetidas .
Ferula foetidas .
Ferula harmoni .
Ferula hermoni .
Ferulas .
Zallouhs .
foetida, Ferula .
harmonis, Ferula .
hermonis, Ferula .
Asafoetida .
Ferula assafoetida .
Ferula assa foetida .
Devil's Dung .
Stinking Gum .
Asant .
Food of the Gods .
Kaayam .
A plant genus of the family APIACEAE. It contains pungent oils and resins. It is used to flavor curries, as a carminative, and as cat and dog repellent. The occasionally used common name of 'giant fennel' should not be confused with true fennel (FOENICULUM). .
0.71

Asarum .
Asarum canadense .
Asarum canadenses .
Asarums .
Canada Snakeroots .
Gingers, Wild .
Snakeroots, Canada .
Wild Gingers .
canadense, Asarum .
Canada Snakeroot .
Ginger, Wild .
Snakeroot, Canada .
Wild Ginger .
A plant genus of the family ARISTOLOCHIACEAE which was used medicinally by North American Indians. The common name of 'snakeroot' is also used for many other plants, including SANICULA; or ARISTOLOCHIA; or Polygala. .
0.64

Aspirin, Dipyridamole Drug Combination .
Aggrenox .
Asasantin .
Asasantin Retard .
Aspirin-Dipyridamole Drug Combination .
Extended-Release Dipyridamole-Aspirin .
TX 3301 .
TX-3301 .
3301, TX .
Aspirin Dipyridamole Drug Combination .
Combination, Aspirin-Dipyridamole Drug .
Dipyridamole-Aspirin, Extended-Release .
Drug Combination, Aspirin-Dipyridamole .
Extended Release Dipyridamole Aspirin .
Retard, Asasantin .
A drug combination of aspirin and dipyridamole that functions as a PLATELET AGGREGATION INHIBITOR, used to prevent THROMBOSIS and STROKE in TRANSIENT ISCHEMIC ATTACK patients. .
0.64

Argininosuccinic Aciduria .
ASA Deficiency .
ASL Deficiency .
Argininosuccinase Deficiency .
Argininosuccinate Acidemia .
Argininosuccinate Lyase Deficiency .
Argininosuccinic Acid Lyase Deficiency .
Argininosuccinic Acidemia .
Argininosuccinicaciduria .
Argininosuccinyl-Coa Lyase Deficiency .
Arginosuccinase Deficiency .
Asauria .
Inborn Error of Urea Synthesis, Arginino Succinic Type .
Urea Cycle Disorder, Arginino Succinase Type .
ASA Deficiencies .
ASL Deficiencies .
Acidemia, Argininosuccinate .
Acidemias, Argininosuccinate .
Aciduria, Argininosuccinic .
Acidurias, Argininosuccinic .
Arginino Succinase Deficiencies .
Argininosuccinate Acidemias .
Argininosuccinate Lyase Deficiencies .
Argininosuccinic Acidurias .
Argininosuccinicacidurias .
Deficiencies, ASA .
Deficiencies, ASL .
Deficiencies, Arginino Succinase .
Deficiencies, Argininosuccinate Lyase .
Deficiency, ASA .
Deficiency, ASL .
Deficiency, Arginino Succinase .
Deficiency, Argininosuccinate Lyase .
Arginino Succinase Deficiency .
Rare autosomal recessive disorder of the urea cycle which leads to the accumulation of argininosuccinic acid in body fluids and severe HYPERAMMONEMIA. Clinical features of the neonatal onset of the disorder include poor feeding, vomiting, lethargy, seizures, tachypnea, coma, and death. Later onset results in milder set of clinical features including vomiting, failure to thrive, irritability, behavioral problems, or psychomotor retardation. Mutations in the ARGININOSUCCINATE LYASE gene cause the disorder. .
0.62

Asarum europaeum .
Asarum ibericum .
Asarabacca .
European Wild Ginger .
Haselwort .
Wild Spikenard .
Homeopathic remedy. Asarum ibericum. Asarabacca, European Wild Ginger, Haselwort, Wild Spikenard. Abbrev.: "asar.". Plant origin. Original habitat: Europe and Asia. Parts used: whole plant. Note: P.S.- There is pathogenetic study for this substance. .
0.54